(A-H) Chrdl1 regulates synaptic GluA2 levels. (A,E) Example images of WT (top) and Chrdl1 KO
(bottom) P14 visual cortex sections immunostained for GluA2 and VGlut2 (A) or VGlut1 (E).
(B-D,F-H) Quantification of immunostaining: Chrdl1 KO shows significant decrease in GluA2 at thalamocortical
VGlut2 synapses (B) and intracortical VGlut1 synapses (F); significant decrease in GluA2 puncta
(C,G); significant decrease in presynaptic VGlut2 puncta (D) with no difference in VGlut1
(H). N=6 WT, 6 KO mice VGlut2 and VGlut1. (I-P) Chrdl1 regulates thalamocortical synapse formation.
(I,M) Example images of WT (top) and Chrdl1 KO (bottom) P14 visual cortex sections immunostained for PSD95 and
VGlut2 (I) or VGlut1 (M). (J-L,N-P) Quantification of immunostaining: Chrdl1 KO shows
significant decrease in colocalization of PSD95 with VGlut2 at thalamocortical synapses (J); no change in
colocalization of PSD95 with VGlut1 at intracortical synapses (N); no change in PSD95 puncta (K,O);
significant decrease in presynaptic VGlut2 puncta (L) with no difference in VGlut1 (P). N=6 WT, 6 KO
mice VGlut2; N=5 WT, 5 KO mice VGlut1. (Q-X) Chrdl1 regulates thalamocortical synaptic GluA1. (Q,U)
Example images of WT (top) and Chrdl1 KO (bottom) P14 visual cortex sections immunostained for GluA1 and VGlut2 (Q)
or VGlut1 (U). (R-T,V-X) Quantification of immunostaining: Chrdl1 KO shows significant decrease in
colocalization of GluA1 with VGlut2 at thalamocortical synapses (R); no change in colocalization of GluA1 with VGlut1
at intracortical synapses (V); no large change in GluA1 puncta (S,W); significant decrease in
presynaptic VGlut2 puncta (T) with no difference in VGlut1 (X). N=5 WT, 5 KO mice VGlut2 and VGlut1.
Scale bar = 5μm. Bar graphs mean±s.e.m., with individual data points representing mice. Statistics by T-test,
significance as stated on graph. See also Figure S4,S5,S6; Tables S2,S3,S4.